Crystal structure of (E)-4-(6-(4-(2-(pyridin-4-yl)vinyl)phenoxy)pyrimidin-4-yl)morpholine, C21H20N4O2
C21H20N4O2, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.874(3) Å, b = 16.526(7) Å, c = 20.147(8) Å, α = 67.140(5)°, β = 83.287(6)°, γ = 86.910(6)°, V = 1789.7(14) Å3, Z = 4, Rgt(F) = 0.0614, wRref(F2) = 0.1675, T = 296 K.
Saved in:
Main Authors: | Bai Su-Fen, Liu Jia-Xuan, Li Shan-Shan, Tian Chun-Yu, La Xiao-Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2022-08-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Subjects: | |
Online Access: | https://doi.org/10.1515/ncrs-2022-0045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Basic Ionic Liquid as Catalyst in Synthesis of Dimethyl 4-(2-(2,6-Bis(methoxycarbonyl)pyridine-4-yl)vinyl)pyridine-2,6-dicarboxylate
by: Xiaobing Liu, et al.
Published: (2018-01-01) -
Methyl 2-amino-4-(morpholin-4-yl)benzo[d]thiazole-6-carboxylate tetartohydrate
by: Erik Uran, et al.
Published: (2025-01-01) -
Synthesis and Biological Activity of Some 3,4-Dihydro-4-(4-substituted aryl)-6-(naptho[2,1-b]furan-2-yl pyrimidine-2(1H)-one Derivatives
by: Sanjeevan S. Gaikwad, et al.
Published: (2012-01-01) -
Synthesis and biological evaluation of 4-(1H-imidazol-2-yl)-2-(pyrimidin-5-yl)oxazoles as potent anticancer agents
by: Divya Komirishetti, et al.
Published: (2025-01-01) -
Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
by: Pan Nian-Juan, et al.
Published: (2023-10-01)